Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2021
January 2021, Vol 11, No 1
January 2021, Vol 11, No 1
The Oncology Pipeline: Innovation Continues to Drive Progress
AVBCC Summit Highlights
Total growth in the oncology pipeline in 2020 has been driven by targeted therapies, said Doug Long, Vice President, Industry Relations, IQVIA, at the 10th Annual Summit of the Association for Value-Based Cancer Care (AVBCC) in 2020.
Read More ›
Research Reveals Barriers to Clinical Trial Participation
By
Charlie Dawson
Quality Care Symposium
Enrollment in clinical trials is vital for the advancement of knowledge and improvement of patient outcomes, but few adults participate in cancer clinical trials. The numbers are even lower among minority adolescent and young adults (AYAs).
Read More ›
Is Your Compliance Plan Working For or Against You?
By
Meg Barbor, MPH
Healthcare Administration
The government now expects healthcare providers and suppliers to have effective compliance programs in place, but a compliance plan only works for you when you are working with it, according to Robert W. Liles, JD, MBA, MS, Managing Partner, Liles Parker, PLLC, Washington, DC, and Paul Weidenfeld, JD, Co-Founder, Exclusion Screening, Washington, DC, who hosted a lively discussion on the ins and outs of effective compliance plans and the laws surrounding them at the virtual 2020 Healthcare Administration Alliance Conference.
Read More ›
Payers’ Perspectives on Cancer Care
AVBCC Summit Highlights
In an environment of increasing vertical and horizontal integration in healthcare, are new value-based care models in oncology—such as the Centers for Medicare & Medicaid Services’ pilot payment project, the Oncology Care Model (OCM)—working? Five years from now, will we still be talking about efforts to go from volume to value using alternative payment models?
Read More ›
HIPAA and COVID-19: What Healthcare Providers Need to Know
By
Audrey E. Coaxum, CHC, CEMC, CPC, CMC, CMIS, CMOM, CMCO, CMCA-E/M
Healthcare Administration
The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule protects the privacy of patients’ health information (protected health information [PHI]) but is balanced to ensure appropriate use and disclosure of the information when necessary to treat a patient, to protect the nation’s public health, and for other critical purposes.
Read More ›
Financial Hardship Affects Long-Term Outcomes for Patients with Cancer
By
Charlie Dawson
Quality Care Symposium
Protecting patients with cancer from financial hardship can save more than money. According to data presented at the 2020 ASCO Quality Care Symposium, mitigating the financial burden of cancer treatment on patients may save lives as well.
Read More ›
The Impact of Social Determinants of Health on Cancer Care
By
Charlie Dawson
Quality Care Symposium
Cancer does not discriminate based on social status, race, income, or education, but that does not mean that it is an equal-opportunity killer. Evidence shows that overall, patients with poorer socioeconomic status also have poorer health outcomes compared with those with good socioeconomic status. The American Society of Clinical Oncology (ASCO) has recently launched a program to address the role of social determinants of health in cancer care and cancer outcomes.
Read More ›
What Is the Best Approach for Treating High-Risk Smoldering Myeloma?
By
Patricia Stewart
Hematologic Malignancies
Although smoldering myeloma is acknowledged as a clinical entity, debate continues about whether to treat, when to treat, and how to treat this condition, said Natalie S. Callander, MD, Leader, Myeloma/Lymphoma Disease-Oriented Team, University of Wisconsin Carbone Cancer Center, Madison, at the National Comprehensive Cancer Network (NCCN) 2020 Virtual Congress: hematologic malignancies.
Read More ›
Dual RAF/MEK Inhibitor Shows Promising Activity in Tumors with RAS/RAF Mutations
By
William King
Personalized Medicine
VS-6766, a unique inhibitor of the
RAF/MEK
-signaling pathway, has shown antitumor activity in
RAS/RAF
mutation–positive solid tumors and in multiple myeloma, when administered on an intermittent dosing schedule, according to recently published data.
Read More ›
Strategies to Support Your Team During Uncertain Times
By
Mary Bailey
Practice Management
Medical practices across the United States have undergone major transformations in response to the challenges posed by the COVID-19 pandemic. Physicians, nurses, pharmacists, and administrators alike have been required to adapt rapidly to shifting protocols and unprecedented demands. These healthcare workers are facing multiple stressors, serious safety concerns, and economic upheavals, which put them at risk for anxiety, depression, and burnout as they work tirelessly to provide services for their patients. Leaders play an important role in supporting their employees during these particularly difficult times.
Read More ›
Page 1 of 2
1
2
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Molecular Characteristics Increasingly Define Adult Gliomas
By
William King
2.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
By
William King
3.
Optimal Systemic Therapy for Renal Cell Carcinoma Is Still Evolving
By
William King
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes